CAH Technical Analysis
CAH Technical Analysis Data
As of date:9/22/2022
CAH stock price:67.27
CAH 50 DMA:64.64
CAH 200 DMA:56.44
CAH MACD (200-50):-8.20
CAH RSI:30.88
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)30.88
Extremely
Oversold

Also see:
CAH Market Cap History
CAH Shares Outstanding History
CAH YTD Return

Try ChartSweeps today
CAH Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree CAH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
CAH Stock Price Chart
Technical Analysis News

FXH Getting Very Oversold
2 hours, 18 minutes ago


FXG Crosses Critical Technical Indicator
2 hours, 20 minutes ago


Shares of FXE Now Oversold
2 hours, 22 minutes ago


Shares of FVD Now Oversold
2 hours, 22 minutes ago


FTLS Enters Oversold Territory
2 hours, 25 minutes ago


GasLog Partners (GLOP) Shares Cross Below 200 DMA
2 hours, 25 minutes ago


Antero Resources (AR) Shares Cross Below 200 DMA
2 hours, 27 minutes ago


FTEC Getting Very Oversold
2 hours, 27 minutes ago


FNDX Getting Very Oversold
2 hours, 37 minutes ago


Sisecam Resources (SIRE) Shares Cross Below 200 DMA
2 hours, 37 minutes ago


FNDF Enters Oversold Territory
2 hours, 37 minutes ago


Shares of FNDB Now Oversold
2 hours, 37 minutes ago


Western Midstream Partners Breaks Below 200-Day Moving Average - Notable for WES
2 hours, 44 minutes ago


UAN Crosses Below Key Moving Average Level
2 hours, 44 minutes ago


ARCO Makes Notable Cross Below Critical Moving Average
2 hours, 44 minutes ago


More Technical Analysis News

CAH Technical Analysis Charts
CAH Technical AnalysisCAH RSI
About Cardinal Health, Inc.
Cardinal Health is a healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. Co. manages its business in two segments: Pharmaceutical and Medical. Co.'s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the U.S. Co.'s Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the U.S., Canada, Europe, Asia and other markets.

When researching a stock like Cardinal Health, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from CAH Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for CAH stock — the real life supply and demand for the stock over time — and examines that data in different ways.
Featured Slideshows
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
CAH Technical Analysis Charts
CAH DMACAH MACD
Video: Technical Analysis
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CAH Technical Analysis Peers
Cardinal Health (CAH) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

CI Technical Analysis
CNC Technical Analysis
COO Technical Analysis
CRL Technical Analysis
CTLT Technical Analysis
CVS Technical Analysis
DGX Technical Analysis
DHR Technical Analysis
DVA Technical Analysis
DXCM Technical Analysis
More Healthcare companies »

 

CAH Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2022, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.